CapitalSource is a leading commercial lending, investment and asset management business focused on the middle market operating through three focused lending businesses: Structured Finance, Healthcare and Specialty Finance and Corporate Finance. Headquartered in Chevy Chase, Maryland, CapitalSource has a national network of offices in cities including: Atlanta, Boston, Buffalo, Chicago, Dallas, Los Angeles, Nashville, New York, Philadelphia, St. Louis and San Francisco.
The Healthcare and Specialty Finance team at CapitalSource includes five groups: Asset-Backed Lending, CapitalSource Mortgage Finance, Health Care Credit Group, Health Care Real Estate Group and Security Lending Group. The CapitalSource Mortgage Finance Group is their FHA/HUD lending subsidiary. The Health Care Credit Group is responsible for all non-real estate healthcare lending activities. The Health Care Real Estate Group is responsible for all healthcare real estate lending activities, and the Security Lending Group is responsible for financing activities related to the physical security industry.
CapitalSource’s range of investment products includes: revolving lines of credit, mortgage debt financing, cash flow financing, acquisition loans, bridge loans, mezzanine financing, debtor-in-possession financing, and HUD financing.
City: Chevy Chase
CapitalSource In The News
- In-Depth: Advances and challenges in digital dermatology
- 20% of physicians prefer hospital employment, survey finds
- Tour the Bravern’s new Life Time Athletic luxury athletic club and spa (Photos)
- Advocate Aurora Health plans first post-merger bond sale: 5 things to know
- 20 most beautiful hospitals in America, as ranked by Soliant
- Mallinckrodt, Endo sue drug dealers & online marketplaces over illegal opioid sales: 7 things to know
- How Illinois hospital nurses are improving care for sexual assault patients
- Texas Research Park gets new leasing and marketing partner
- Ex-drug company executive gets 15 years in prison for $50M pill distribution plot
- Dr. Ezekiel Emanuel: End-of-life care not improving fast enough